Cargando…
Response to: Broadbent 2020, Better the drug you know: Commentary on “Daughton 2020, Natural experiment concept to accelerate the re-purposing of existing therapeutics for Covid-19”
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241324/ https://www.ncbi.nlm.nih.gov/pubmed/32501449 http://dx.doi.org/10.1016/j.gloepi.2020.100028 |
_version_ | 1783537046253469696 |
---|---|
author | Daughton, Christian G. |
author_facet | Daughton, Christian G. |
author_sort | Daughton, Christian G. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7241324 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72413242020-05-21 Response to: Broadbent 2020, Better the drug you know: Commentary on “Daughton 2020, Natural experiment concept to accelerate the re-purposing of existing therapeutics for Covid-19” Daughton, Christian G. Glob Epidemiol Commentary Published by Elsevier Inc. 2020-11 2020-05-21 /pmc/articles/PMC7241324/ /pubmed/32501449 http://dx.doi.org/10.1016/j.gloepi.2020.100028 Text en © 2020 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Commentary Daughton, Christian G. Response to: Broadbent 2020, Better the drug you know: Commentary on “Daughton 2020, Natural experiment concept to accelerate the re-purposing of existing therapeutics for Covid-19” |
title | Response to: Broadbent 2020, Better the drug you know: Commentary on “Daughton 2020, Natural experiment concept to accelerate the re-purposing of existing therapeutics for Covid-19” |
title_full | Response to: Broadbent 2020, Better the drug you know: Commentary on “Daughton 2020, Natural experiment concept to accelerate the re-purposing of existing therapeutics for Covid-19” |
title_fullStr | Response to: Broadbent 2020, Better the drug you know: Commentary on “Daughton 2020, Natural experiment concept to accelerate the re-purposing of existing therapeutics for Covid-19” |
title_full_unstemmed | Response to: Broadbent 2020, Better the drug you know: Commentary on “Daughton 2020, Natural experiment concept to accelerate the re-purposing of existing therapeutics for Covid-19” |
title_short | Response to: Broadbent 2020, Better the drug you know: Commentary on “Daughton 2020, Natural experiment concept to accelerate the re-purposing of existing therapeutics for Covid-19” |
title_sort | response to: broadbent 2020, better the drug you know: commentary on “daughton 2020, natural experiment concept to accelerate the re-purposing of existing therapeutics for covid-19” |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241324/ https://www.ncbi.nlm.nih.gov/pubmed/32501449 http://dx.doi.org/10.1016/j.gloepi.2020.100028 |
work_keys_str_mv | AT daughtonchristiang responsetobroadbent2020betterthedrugyouknowcommentaryondaughton2020naturalexperimentconcepttoacceleratetherepurposingofexistingtherapeuticsforcovid19 |